Pepponi, Miriam; Berti, Valentina; Fasciglione, Elsa; Montanini, Flavio; Canu, Letizia; Hubele, Fabrice; Abenavoli, Elisabetta; Briganti, Vittorio; Rapizzi, Elena; Charpiot, Anne; Taieb, David; Pacak, Karel; Goichot, Bernard; Imperiale, Alessio (2024). [68Ga]DOTATOC PET-derived radiomics to predict genetic background of head and neck paragangliomas: a pilot investigation. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, pp. 0-0, ISSN:1619-7070 DOI  

  Cosso, Federica; Lavacchi, Daniele; Messerini, Luca; Briganti, Vittorio; Castiglione, Francesca; Brugia, Marco; Berti, Valentina; Fancelli, Sara; Cianchi, Fabio; Vannini, Agnese; Pillozzi, Serena; Antonuzzo, Lorenzo (2024). Pathological complete response achieved with FLOT chemotherapy in two patients with MSI-H esophagogastric junction and gastric adenocarcinoma. ANTI-CANCER DRUGS, pp. 1-3, ISSN:0959-4973 DOI  

  Linguanti, Flavia; Abenavoli, Elisabetta M; Briganti, Vittorio; Danti, Ginevra; Lavacchi, Daniele; Matteini, Maria; Vaggelli, Luca; Novelli, Luca; Grosso, Anna M; Mungai, Francesco; Mini, Enrico; Antonuzzo, Lorenzo; Miele, Vittorio; Sciagrà, Roberto; Berti, Valentina (2022). Added prognostic value of molecular imaging parameters over proliferation index in typical lung carcinoid: an [18F]FDG PET/CT and SSTR imaging study. ANNALS OF NUCLEAR MEDICINE, vol. -, pp. 1-9, ISSN:0914-7187 DOI  

  Lavacchi D.; Voltolini L.; Comin C.E.; Mazzoni F.; Baldi G.G.; Briganti V.; Luvara S.; Bongiolatti S.; Antonuzzo L. (2021). Primary pleural epithelioid hemangioendothelioma: case report and review of the literature. ANTI-CANCER DRUGS, vol. 32, pp. 1131-1137, ISSN:1473-5741 DOI  

  Lavacchi, Daniele; Antonuzzo, Lorenzo; Briganti, Vittorio; Berti, Valentina; Abenavoli, Elisabetta Maria; Linguanti, Flavia; Messerini, Luca; Giaccone, Giuseppe (2020). Metastatic intracranial solitary fibrous tumors/hemangiopericytomas: description of two cases with radically different behaviors and review of the literature. ANTI-CANCER DRUGS, pp. 0-0, ISSN:0959-4973 DOI  

  Abenavoli E.; Linguanti F.; Briganti V.; Ciaccio A.; Danti G.; Miele V.; Mungai F.; Sciagrà Roberto.; Berti V. (2020). Typical lung carcinoids: review of classification, radiological signs and nuclear imaging findings. CLINICAL AND TRANSLATIONAL IMAGING, vol. 8, pp. 79-94, ISSN:2281-5872 DOI  

  Danti G.; Berti V.; Abenavoli E.; Briganti V.; Linguanti F.; Mungai F.; Pradella S.; Miele V. (2020). Diagnostic imaging of typical lung carcinoids: relationship between MDCT, 111In-Octreoscan and 18F-FDG-PET imaging features with Ki-67 index. LA RADIOLOGIA MEDICA, pp. 0-0, ISSN:0033-8362 DOI  

  Caliri M.; Verdiani V.; Mannucci E.; Briganti V.; Landoni L.; Esposito A.; Burato G.; Rotella C.M.; Mannelli M.; Peri A. (2018). A case of malignant insulinoma responsive to somatostatin analogs treatment. BMC ENDOCRINE DISORDERS, vol. 18, pp. 98-98, ISSN:1472-6823 DOI   Accesso ONLINE all'editore

  Canu L.; Pradella S.; Rapizzi E.; Fucci R.; Valeri A.; Briganti V.; Giache V.; Parenti G.; Ercolino T.; Mannelli M. (2017). Sunitinib in the therapy of malignant paragangliomas: Report on the efficacy in a sdhb mutation carrier and review of the literature. ARCHIVES OF ENDOCRINOLOGY AND METABOLISM, vol. 61, pp. 90-97, ISSN:2359-3997 DOI  

  Castello, Angelo; Briganti, Vittorio; Sciagrà, Roberto (2016). Interventricular septum metastasis in neuroendocrine tumour. ENDOCRINE, vol. 53, pp. 870-871, ISSN:1355-008X DOI   Accesso ONLINE all'editore

  C. Orlando; C. C. Raggi; L. Bagnoni; R. Sestini; V. Briganti; G. La Cava; G. Bernini; G. P. Tonini; M. Pazzagli; M. Serio; M. Maggi (2001). Somatostatin receptor type 2 gene expression in neuroblastoma, measured by competitive RT-PCR, is related to patient survival and to somatostatin receptor imaging by indium -111-pentetreotide.. MEDICAL AND PEDIATRIC ONCOLOGY, vol. 36, pp. 224-226, ISSN:0098-1532

  BRIGANTI V; SESTINI R; C. ORLANDO; BERNINI G; LA CAVA G; TAMBURINI A; RAGGI; SERIO M; MAGGI M (1997). Imaging of somatostatin receptors by indium-111-pentetreotide correlates with quantitative determination of somatostatin receptor type 2 gene expression in neuroblastoma tumors.. CLINICAL CANCER RESEARCH, vol. 3, pp. 2385-2391, ISSN:1078-0432, American Association of Cancer Research:150 South Independence Mall West, #826:Philadelphia, PA 19106:(215)440-9300, EMAIL: pubs@aacr.org, INTERNET: http://www.aacr.org, Fax: (215)440-7228: